ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

ClinicalTrials.gov ID: NCT00075959

Public ClinicalTrials.gov record NCT00075959. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 1:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

CHANT (Cerebral Hemorrhage And NXY Treatment) A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter, Phase IIb Study to Assess the Safety and Tolerability of Intravenous Infusion of NXY-059 in Adult Patients With Acute Intracerebral Hemorrhage (ICH)

Study identification

NCT ID
NCT00075959
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
600 participants

Conditions and interventions

Interventions

  • NXY-059 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2004
Primary completion
Dec 31, 2005
Completion
Dec 31, 2005
Last update posted
Jan 3, 2013

2004 – 2006

United States locations

U.S. sites
64
U.S. states
30
U.S. cities
64
Facility City State ZIP Site status
Research Site Birmingham Alabama
Research Site Scottsdale Arizona
Research Site Fort Smith Arkansas
Research Site Carmichael California
Research Site Sacramento California
Research Site San Diego California
Research Site San Jose California
Research Site Santa Rosa California
Research Site Walnut Creek California
Research Site Danbury Connecticut
Research Site Melbourne Florida
Research Site Ocala Florida
Research Site Pompano Beach Florida
Research Site Port Charlotte Florida
Research Site Punta Gorda Florida
Research Site Tampa Florida
Research Site Weston Florida
Research Site Atlanta Georgia
Research Site Decatur Georgia
Research Site Duluth Georgia
Research Site Lawrenceville Georgia
Research Site Honolulu Hawaii
Research Site Arlington Heights Illinois
Research Site Maywood Illinois
Research Site Fort Wayne Indiana
Research Site Des Moines Iowa
Research Site Louisville Kentucky
Research Site Marrero Louisiana
Research Site Shreveport Louisiana
Research Site South Weymouth Massachusetts
Research Site Worcester Massachusetts
Research Site Ann Arbor Michigan
Research Site East Lansing Michigan
Research Site Robbinsdale Minnesota
Research Site Kansas City Missouri
Research Site Omaha Nebraska
Research Site Reno Nevada
Research Site Edison New Jersey
Research Site Holmdel New Jersey
Research Site Morristown New Jersey
Research Site Ridgewood New Jersey
Research Site Summit New Jersey
Research Site Manhasset New York
Research Site Schenectady New York
Research Site Durham North Carolina
Research Site Winston-Salem North Carolina
Research Site Akron Ohio
Research Site Cleveland Ohio
Research Site Toledo Ohio
Research Site Youngstown Ohio
Research Site Oklahoma City Oklahoma
Research Site Abington Pennsylvania
Research Site Danville Pennsylvania
Research Site Hershey Pennsylvania
Research Site Philadelphia Pennsylvania
Research Site Pittsburgh Pennsylvania
Research Site Bristol Tennessee
Research Site Memphis Tennessee
Research Site Houston Texas
Research Site Lubbock Texas
Research Site Virginia Beach Virginia
Research Site Olympia Washington
Research Site Madison Wisconsin
Research Site Marshfield Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00075959, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 3, 2013 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00075959 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →